help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ojamaa, K.
Right arrow Articles by Klein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ojamaa, K.
Right arrow Articles by Klein, I.
Endocrinology Vol. 141, No. 6 2139-2144
Copyright © 2000 by The Endocrine Society

ARTICLES

Thyroid Hormone Regulation of Phospholamban Phosphorylation in the Rat Heart1

Kaie Ojamaa, Agnes Kenessey and Irwin Klein

Department of Medicine, Division of Endocrinology, North Shore University Hospital; and Departments of Medicine and Cell Biology, New York University School of Medicine, Manhasset, New York 11030

Address all correspondence and requests for reprints to: Dr. Kaie Ojamaa, Division of Endocrinology, North Shore University Hospital, 300 Community Drive, Manhasset, New York 11030.

Thyroid hormone exerts predictable effects on the contractile performance of the heart in part by regulating the transcription of genes encoding specific calcium transporter proteins. In a rat model of hypothyroidism, left ventricular (LV) contractile function as measured by ejection fraction was decreased by 22% (P < 0.05), and this was returned to control values with T3 treatment. In confirmation of prior studies, LV phospholamban (PLB) protein content was significantly decreased by 25% and 40% compared with hypothyroid LV when the animals were treated with T3 at two doses, 2.5 and 7.0 µg/day, respectively. The ratio of sarcoplasmic reticulum calcium adenosine triphosphatase (SERCA2) to PLB protein content was thus increased by 171% and 207%, respectively (P < 0.01). Resolution of the phosphorylated PLB pentamers by SDS-PAGE showed that T3 infusion at 2.5 and 7.0 µg/day decreased (P < 0.001) the amount nonphosphorylated pentamers by 82% and 95%, respectively, in a dose-dependent manner. T3 treatment produced an increase in the proportion of highly phosphorylated PLB pentamers (more than five phosphates) when expressed as a fraction of total pentameric molecules (P < 0.05). Site-specific antibodies showed that the T3-induced increase in phosphorylated PLB pentamers was the result of an increase in both serine 16 and threonine 17 phosphorylation. We conclude that thyroid hormone, in addition to regulating the expression of cardiac PLB, is able to alter the degree of PLB phosphorylation, which correlates with enhancement of LV contractile function. These studies suggest that T3 may augment myocyte calcium cycling via changes in both cAMP- and calcium/calmodulin-dependent protein kinase activities.




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. A. Carrillo-Sepulveda, G. S. Ceravolo, Z. B. Fortes, M. H. Carvalho, R. C. Tostes, F. R. Laurindo, R. C. Webb, and M. L. M. Barreto-Chaves
Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes
Cardiovasc Res, October 6, 2009; (2009) cvp304v2.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. A. Ketzer, A. P. Arruda, D. P. Carvalho, and L. de Meis
Cardiac sarcoplasmic reticulum Ca2+-ATPase: heat production and phospholamban alterations promoted by cold exposure and thyroid hormone
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H556 - H563.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. van Rooij, L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. Olson
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
Science, April 27, 2007; 316(5824): 575 - 579.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Ukropec, R. P. Anunciado, Y. Ravussin, M. W. Hulver, and L. P. Kozak
UCP1-independent Thermogenesis in White Adipose Tissue of Cold-acclimated Ucp1-/- Mice
J. Biol. Chem., October 20, 2006; 281(42): 31894 - 31908.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
M. Armigliato, R. Paolini, S. Aggio, S. Zamboni, M. P. Galasso, P. Zonzin, and G. Cella
Hyperthyroidism as a Cause of Pulmonary Arterial Hypertension: A Prospective Study
Angiology, October 1, 2006; 57(5): 600 - 606.
[Abstract] [PDF]

Home page
 CirculationHome page
A. M. Ranasinghe, C. J. McCabe, D. W. Quinn, S. R. James, D. Pagano, J. A. Franklyn, and R. S. Bonser
How Does Glucose Insulin Potassium Improve Hemodynamic Performance?: Evidence for Altered Expression of Beta-Adrenoreceptor and Calcium Handling Genes
Circulation, July 4, 2006; 114(1_suppl): I-239 - I-244.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
G. M. Ledda-Columbano, F. Molotzu, M. Pibiri, C. Cossu, A. Perra, and A. Columbano
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes
FASEB J, January 1, 2006; 20(1): 87 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. J. Kahaly and W. H. Dillmann
Thyroid Hormone Action in the Heart
Endocr. Rev., August 1, 2005; 26(5): 704 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. D. Carvalho-Bianco, B. W. Kim, J. X. Zhang, J. W. Harney, R. S. Ribeiro, B. Gereben, A. C. Bianco, U. Mende, and P. R. Larsen
Chronic Cardiac-Specific Thyrotoxicosis Increases Myocardial {beta}-Adrenergic Responsiveness
Mol. Endocrinol., July 1, 2004; 18(7): 1840 - 1849.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. M. Ortiga-Carvalho, K. Hashimoto, C. C. Pazos-Moura, D. Geenen, R. Cohen, R. M. Lang, and F. E. Wondisford
Thyroid Hormone Resistance in the Heart: Role of the Thyroid Hormone Receptor {beta} Isoform
Endocrinology, April 1, 2004; 145(4): 1625 - 1633.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
M. D. Fischer, J. R. Gorospe, E. Felder, S. Bogdanovich, F. Pedrosa-Domellof, R. S. Ahima, N. A. Rubinstein, E. P. Hoffman, and T. S. Khurana
Expression profiling reveals metabolic and structural components of extraocular muscles
Physiol Genomics, May 10, 2002; 9(2): 71 - 84.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Shenoy, I. Klein, and K. Ojamaa
Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1690 - H1696.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Klein and K. Ojamaa
Thyroid Hormone : Targeting the Vascular Smooth Muscle Cell
Circ. Res., February 16, 2001; 88(3): 260 - 261.
[Full Text] [PDF]

Home page
 NEJMHome page
I. Klein and K. Ojamaa
Thyroid Hormone and the Cardiovascular System
N. Engl. J. Med., February 15, 2001; 344(7): 501 - 509.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Ojamaa, A. Kenessey, R. Shenoy, and I. Klein
Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1319 - E1324.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society